A phase I trial of OPNT-002 for the treatment of alcohol use disorder
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2017
At a glance
- Drugs OPNT 002 (Primary)
- Indications Alcoholism
- Focus Adverse reactions
- 19 Jul 2017 Results published in an Opiant Pharmaceuticals Media Release.
- 19 Jul 2017 According to an Opiant Pharmaceuticals media release, This study was conducted under a clinical trial agreement between Opiant and the National Institute of Drug Abuse (NIDA), a division of the National Institutes of Health (NIH).
- 07 Mar 2017 New trial record